Literature DB >> 11956217

RYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6.

Elisabeth Trivier1, Trivadi S Ganesan.   

Abstract

RYK is an atypical orphan receptor tyrosine kinase that lacks detectable kinase activity. Nevertheless, using a chimeric receptor approach, we previously found that RYK can signal via the mitogen-activated protein kinase pathway. Recently, it has been shown that murine Ryk can bind to and be phosphorylated by the ephrin receptors EphB2 and EphB3. In this study, we show that human RYK associates with EphB2 and EphB3 but is not phosphorylated by them. This association requires both the extracellular and cytoplasmic domains of RYK and is not dependent on activation of the Eph receptors. It was also previously shown that AF-6 (afadin), a PDZ domain-containing protein, associates with murine Ryk. We show here that AF-6 does not bind to human RYK in vitro or in vivo. This suggests that there are significant functional differences between human and murine RYK. Further studies are required to determine whether RYK modulates the signaling of EphB2 and EphB3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956217     DOI: 10.1074/jbc.M202486200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Eph and ephrin signaling in mammary gland morphogenesis and cancer.

Authors:  Anne-Catherine Andres; Andrew Ziemiecki
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

Review 2.  Eph/ephrin signaling: networks.

Authors:  Dina Arvanitis; Alice Davy
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

3.  The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

Authors:  Michael D Paul; Kalina Hristova
Journal:  Chem Rev       Date:  2018-12-27       Impact factor: 60.622

Review 4.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

Review 5.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

6.  STRUBBELIG defines a receptor kinase-mediated signaling pathway regulating organ development in Arabidopsis.

Authors:  David Chevalier; Martine Batoux; Lynette Fulton; Karen Pfister; Ram Kishor Yadav; Maja Schellenberg; Kay Schneitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

7.  Human epicardial cell-conditioned medium contains HGF/IgG complexes that phosphorylate RYK and protect against vascular injury.

Authors:  Krithika S Rao; Alexander Aronshtam; Keara L McElory-Yaggy; Benjamin Bakondi; Peter VanBuren; Burton E Sobel; Jeffrey L Spees
Journal:  Cardiovasc Res       Date:  2015-05-29       Impact factor: 10.787

8.  Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.

Authors:  Jenny Potratz; Amelie Tillmanns; Philipp Berning; Eberhard Korsching; Christiane Schaefer; Birgit Lechtape; Carolin Schleithoff; Rebekka Unland; Karl-Ludwig Schäfer; Carsten Müller-Tidow; Heribert Jürgens; Uta Dirksen
Journal:  Mol Oncol       Date:  2015-12-20       Impact factor: 6.603

9.  Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms.

Authors:  Li Li; B Ian Hutchins; Katherine Kalil
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 10.  Proteolytic Cleavage of Receptor Tyrosine Kinases.

Authors:  Hao Huang
Journal:  Biomolecules       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.